NO20060992L

2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases

Abstract

This invention presents methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented by the compounds include rheumatoid arthritis and / or its associated symptoms, systemic lupus erythematosus and / or its associated symptoms and multiple sclerosis and its associated symptoms.

Term

No projected expiry on record.

  1. Priority
  2. Filed and published
  3. Today

1 claim: 1 independent, 0 dependent

  1. 1
    R® R®